Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCW Biologics (HCWB) Change in Acquisitions & Divestments (2022 - 2023)

HCW Biologics (HCWB) has disclosed Change in Acquisitions & Divestments for 2 consecutive years, with $10.0 million as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Change in Acquisitions & Divestments fell 41.12% year-over-year to $10.0 million, compared with a TTM value of $10.0 million through Dec 2024, changed 0.0%, and an annual FY2023 reading of $10.0 million, down 59.97% over the prior year.
  • Change in Acquisitions & Divestments was $10.0 million for Q3 2023 at HCW Biologics, down from $17.0 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $17.0 million in Q3 2022 and bottomed at $8.0 million in Q1 2022.